Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 245 clinical trials
None
JUNIPER: A Phase 2 Study to Evaluate the Safety Biological Activity and PK of ND-L02-s0201 in Subjects With IPF

subjects with IPF.

diffusion capacity of the lung for carbon monoxide
forced vital capacity
carbon monoxide
  • 298 views
  • 19 Nov, 2021
  • 40 locations
None
Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

The ILDnose study a multinational, multicenter, prospective, longitudinal study in outpatients with pulmonary fibrosis. The aim is to assess the accuracy of eNose technology as diagnostic tool

  • 0 views
  • 29 Jan, 2021
  • 4 locations
None
Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

Aim: To investigate the efficacy of systemic corticosteroids in treatment for Post-COVID-19 Interstitial Lung Disease. Method: Method: In this multi-centre, prospective, randomised controlled open label clinical trial, patients are divided into two arms: standard treatment arm and standard plus systemic corticosteroid arm. After four weeks, clinical response will being assessed …

respiratory symptom
interstitial lung disease
  • 0 views
  • 08 Aug, 2021
  • 1 location
None
GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis

A placebo-controlled, multicenter, randomized trial to test GKT137831 in ambulatory patients with idiopathic pulmonary fibrosis. This drug is an inhibitor of nicotinamide adenine dinucleotide

idiopathic pulmonary fibrosis
forced vital capacity
pulmonary disease
  • 2 views
  • 29 Oct, 2021
  • 1 location
None
IPF mHealth Exercise

Patients with idiopathic pulmonary fibrosis (IPF) who are stable on antifibrotic therapy at least 3 months will be randomized to complete a 12-week home exercise intervention using an mHealth

diffusion capacity of the lung for carbon monoxide
idiopathic pulmonary fibrosis
nintedanib
carbon monoxide
forced vital capacity
  • 0 views
  • 18 Oct, 2021
  • 1 location
None
Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

up to 28 days in adult subjects with idiopathic pulmonary fibrosis (IPF) alone or in conjunction with local Standard of Care for IPF (pirfenidone or nintedanib). A maximum of 24 evaluable

ofev
idiopathic pulmonary fibrosis
nintedanib
pneumonia
lung biopsy
  • 2 views
  • 03 Nov, 2021
  • 11 locations
None
Tolerability Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis IPF

characteristics of ZSP1603 in IPF patients. The second part was a randomized double-blind placebo-controlled design was used to preliminatively investigate the efficacy and safety of ZSP1603 in the treatment of

diffusion capacity of the lung for carbon monoxide
idiopathic pulmonary fibrosis
  • 0 views
  • 24 Nov, 2021
  • 1 location
None
A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough

To investigate the efficacy and safety of Nalbuphine ER (NAL ER) tablets in subjects diagnosed with Idiopathic Pulmonary Fibrosis (IPF) and evaluate it's treatment of cough in these patients

idiopathic pulmonary fibrosis
pulmonary fibrosis
  • 20 views
  • 19 Nov, 2021
  • 19 locations
None
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis

This is an interventional double-blind randomized controlled trial, to investigate the short and long-term effects of a supervised exercise training program in patients with IPF, depending on

idiopathic pulmonary fibrosis
nintedanib
pirfenidone
pulmonary rehabilitation
  • 162 views
  • 02 Feb, 2021
  • 1 location
None
Genentech Xenon MRI Idiopathic Pulmonary Fibrosis

changes over time in Idiopathic Pulmonary Fibrosis (IPF) patients receiving approved IPF treatments. Subjects will undergo an approximately hour long comprehensive MRI protocol, including

ct scan
pulmonary function test
idiopathic pulmonary fibrosis
nintedanib
dyspnea
  • 0 views
  • 29 Jun, 2021
  • 1 location